Here are five key takeaways:
1. The market is expected to increase at a compound annual growth rate of 15.2 percent.
2. By 2021, the market is projected to reach $2.27 billion.
3. Rising healthcare costs, more focus on patient safety, higher demand for minimally invasive treatments, technological advancements and market consolidation are driving market growth.
4. North America dominates the market, comprising almost 50 percent of the market share. The Asia-Pacific region and Latin America have high potential for growth in the forecasted period.
5. Key market vendors include CAE, Laerdal Medical, 3D Systems, Simulab, Simulaids, Limbs and Things, Kyoto Kagaku, Mentice, Surgical Science Sweden and Gaumard Scientific.
More healthcare news:
Physicians react to CMS’ final MACRA rule — 6 things to know
Senator urges DOJ to reject $465M Mylan settlement — 4 takeaways
The judge has spoken: Anthem, Cigna required to disclose accusatory emails — 5 thoughts
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
